{
  "docId": "019dd923-5fec-763b-95cf-36829236392e",
  "docSlug": "wmIz1K5649XDm8N1ElWG",
  "documentTitle": "See the 24-slide pitch deck a new biotech startup just used to raise $175 million to develop the next cancer breakthrough",
  "authorId": "Pitchdecks",
  "authorName": "Affini-T",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.782,
  "pageNumber": 5,
  "pageCount": 24,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a process-oriented framework to explain the therapeutic strategy.",
  "elementsJson": [
    "action_title",
    "process_diagram"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95cf-36829236392e/5",
  "deckHref": "/decks/019dd923-5fec-763b-95cf-36829236392e",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95cf-36829236392e.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95cf-36829236392e#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.31,
        "x": 0.34,
        "y": 0.338
      },
      "kind": "framework",
      "text": "Right Cells",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0025fe69-e132-4e90-bdcc-4a71b414a1d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.31,
        "x": 0.65,
        "y": 0.338
      },
      "kind": "framework",
      "text": "Right Place",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09e58546-b125-4197-af5f-4223eaff41b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.31,
        "x": 0.028,
        "y": 0.338
      },
      "kind": "framework",
      "text": "Right Targets",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a243aef3-6e49-4b6f-90e7-c736d39f79a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.29,
        "x": 0.035,
        "y": 0.475
      },
      "kind": "list",
      "text": "Solid tumors are dependent on oncogene driver mutations like KRAS; Driver mutations are present in every cancer cell, not in healthy tissues, and cannot be easily lost",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2651d268-c14f-4b29-8dcc-8eadf317edd1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.29,
        "x": 0.35,
        "y": 0.475
      },
      "kind": "list",
      "text": "Coordinate a CD4+ and CD8+ T cell response to sustain anti-tumor activity/response; Select immune cells for stemness and central memory phenotype; Manufacture to maintain cell naiveté and reduce terminal differentiation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6bba855-8fc1-459f-9edc-f1f7bb8d70e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.29,
        "x": 0.66,
        "y": 0.475
      },
      "kind": "list",
      "text": "Direct T cells to traffic into the solid tumor bed using proprietary TCRs; Prevent deletion of T cells by converting Fas/FasL death signal to 41BB survival signal; Convert immunosuppressive tumor microenvironment (TME) signals into stimulatory cues using additional synthetic biology switches",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fad2a0f3-9e7d-47cc-8ea8-d36e9f267631",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.86,
        "x": 0.025,
        "y": 0.135
      },
      "kind": "title",
      "text": "Engineering T cells with the potential to cure hard-to-treat solid tumors",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "052a19d5-d88c-4666-8b17-27f3637137cc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "200e9501-1c68-4f15-a1c5-a660caa7ebab",
      "evidence": "Three-step sequential framework (Right Targets -> Right Cells -> Right Place)",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "d0f80b36-da7f-42d8-9727-d5377b5d65a5",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": null,
      "evidence": "Presents Affini-T's T cell therapies as a potential solution",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "31e0b531-be4a-4a81-9079-49b055f4a596",
      "evidence": "Emphasizes the limitations of current treatments and the potential of Affini-T's T cell therapies",
      "position": 0,
      "objective": "Highlights the need for better cancer treatments",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 5,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "a51a49e1-5271-4281-b207-0de93fbc5072",
      "evidence": "Connects Affini-T's mission to the potential for transformative therapies",
      "position": 1,
      "objective": "Explains the 'why' behind Affini-T's mission",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}